VitaNova Life Sciences (VNOV) Return on Capital Employed Growth (1y) (2023 - 2026)
VitaNova Life Sciences (VNOV) Return on Capital Employed Growth (1y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 1,151.00 |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | -177.00 |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 191.00 |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | 36.00 |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 26.00 |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | 1,612.00 |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -674.00 |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -1,592.00 |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -8,366.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -8,366.00 |
| Jan 31, 2026 | 3,077.00 |
| Oct 31, 2025 | 4,251.00 |
| Jul 31, 2025 | 4,684.00 |
| Apr 30, 2025 | 6,201.00 |
| Apr 30, 2024 | -475.00 |
| Apr 30, 2023 | -14,306.00 |
| Jan 31, 2023 | -22,143.00 |